Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes

Iris M. de Lange; Boudewijn Gunning; Anja C. M. Sonsma; Lisette van Gemert; Marjan van Kempen; Nienke E. Verbeek; Joost Nicolai; Nine V. A. M. Knoers; Bobby P. C. Koeleman; Eva H. Brilstra

doi:10.1111/epi.14191

Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes

Iris M. de Lange^*, Boudewijn Gunning, Anja C. M. Sonsma, Lisette van Gemert, Marjan van Kempen, Nienke E. Verbeek, Joost Nicolai, Nine V. A. M. Knoers, Bobby P. C. Koeleman, Eva H. Brilstra

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1154-1165
Number of pages	12
Journal	Epilepsia
Volume	59
Issue number	6
DOIs	https://doi.org/10.1111/epi.14191
Publication status	Published - Jun 2018

Keywords

cognition
Dravet syndrome
GEFS
SCN1A
sodium-channel blockers
SEVERE MYOCLONIC EPILEPSY
LONG-TERM COURSE
SCN1A MUTATIONS
FEBRILE SEIZURES
SODIUM-CHANNEL
INFANCY
DIAGNOSIS
VARIANTS
GENE
ENCEPHALOPATHY

Access to Document

10.1111/epi.14191Licence: CC BY-NC

Cite this

de Lange, I. M., Gunning, B., Sonsma, A. C. M., van Gemert, L., van Kempen, M., Verbeek, N. E., Nicolai, J., Knoers, N. V. A. M., Koeleman, B. P. C., & Brilstra, E. H. (2018). Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes. Epilepsia, 59(6), 1154-1165. https://doi.org/10.1111/epi.14191

de Lange, Iris M. ; Gunning, Boudewijn ; Sonsma, Anja C. M. ; van Gemert, Lisette ; van Kempen, Marjan ; Verbeek, Nienke E. ; Nicolai, Joost ; Knoers, Nine V. A. M. ; Koeleman, Bobby P. C. ; Brilstra, Eva H. / Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes. In: Epilepsia. 2018 ; Vol. 59, No. 6. pp. 1154-1165.

@article{e0c7369956864afaa18e96a9cfc86176,

title = "Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes",

keywords = "cognition, Dravet syndrome, GEFS, SCN1A, sodium-channel blockers, SEVERE MYOCLONIC EPILEPSY, LONG-TERM COURSE, SCN1A MUTATIONS, FEBRILE SEIZURES, SODIUM-CHANNEL, INFANCY, DIAGNOSIS, VARIANTS, GENE, ENCEPHALOPATHY",

author = "{de Lange}, {Iris M.} and Boudewijn Gunning and Sonsma, {Anja C. M.} and {van Gemert}, Lisette and {van Kempen}, Marjan and Verbeek, {Nienke E.} and Joost Nicolai and Knoers, {Nine V. A. M.} and Koeleman, {Bobby P. C.} and Brilstra, {Eva H.}",

year = "2018",

month = jun,

doi = "10.1111/epi.14191",

language = "English",

volume = "59",

pages = "1154--1165",

journal = "Epilepsia",

issn = "0013-9580",

publisher = "Wiley",

number = "6",

}

de Lange, IM, Gunning, B, Sonsma, ACM, van Gemert, L, van Kempen, M, Verbeek, NE, Nicolai, J, Knoers, NVAM, Koeleman, BPC & Brilstra, EH 2018, 'Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes', Epilepsia, vol. 59, no. 6, pp. 1154-1165. https://doi.org/10.1111/epi.14191

Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes. / de Lange, Iris M.; Gunning, Boudewijn; Sonsma, Anja C. M.; van Gemert, Lisette; van Kempen, Marjan; Verbeek, Nienke E.; Nicolai, Joost; Knoers, Nine V. A. M.; Koeleman, Bobby P. C.; Brilstra, Eva H.

In: Epilepsia, Vol. 59, No. 6, 06.2018, p. 1154-1165.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes

AU - de Lange, Iris M.

AU - Gunning, Boudewijn

AU - Sonsma, Anja C. M.

AU - van Gemert, Lisette

AU - van Kempen, Marjan

AU - Verbeek, Nienke E.

AU - Nicolai, Joost

AU - Knoers, Nine V. A. M.

AU - Koeleman, Bobby P. C.

AU - Brilstra, Eva H.

PY - 2018/6

Y1 - 2018/6

KW - cognition

KW - Dravet syndrome

KW - GEFS

KW - SCN1A

KW - sodium-channel blockers

KW - SEVERE MYOCLONIC EPILEPSY

KW - LONG-TERM COURSE

KW - SCN1A MUTATIONS

KW - FEBRILE SEIZURES

KW - SODIUM-CHANNEL

KW - INFANCY

KW - DIAGNOSIS

KW - VARIANTS

KW - GENE

KW - ENCEPHALOPATHY

U2 - 10.1111/epi.14191

DO - 10.1111/epi.14191

M3 - Article

C2 - 29750338

VL - 59

SP - 1154

EP - 1165

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 6

ER -